National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments-Reference-Cited by-同舟云学术

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments

Published:2021-05 Issue:5 Volume:84 Page:1254-1268
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gelfand Joel M.,Armstrong April W.,Bell Stacie,Anesi George L.,Blauvelt Andrew,Calabrese Cassandra,Dommasch Erica D.,Feldman Steven R.,Gladman Dafna,Kircik Leon,Lebwohl Mark,Lo Re Vincent,Martin George,Merola Joseph F.,Scher Jose U.,Schwartzman Sergio,Treat James R.,Van Voorhees Abby S.,Ellebrecht Christoph T.,Fenner Justine,Ocon Anthony,Syed Maha N.,Weinstein Erica J.,Gondo George,Heydon Sue,Koons Samantha,Ritchlin Christopher T.

Publisher

Elsevier BV

Subject

Dermatology

Reference83 articles.

1. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: version 1;Gelfand;J Am Acad Dermatol,2020

2. The RAND/UCLA Appropriateness Method User’s Manual;Fitch,2001

3. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study;Yeung;JAMA Dermatol,2013

4. Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the United Kingdom;Takeshita;J Invest Dermatol,2018

5. The risk of stroke in patients with psoriasis;Gelfand;J Invest Dermatol,2009

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 infection in pregnant patients on TNFα inhibitor: Real-life data with a review of literature;Journal of Reproductive Immunology;2024-06

2. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation;Journal of the American Academy of Dermatology;2024-06

3. Management of Psoriasis Patients with Serious Infectious Diseases;Advances in Therapy;2024-05-06

4. Filling the prescription gap: the value of community support in psoriasis management;British Journal of Dermatology;2024-04-18

5. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30